Sex-specific difference in outcome after cardiac resynchronization therapy

Abstract Aims Observation of better outcome in women after cardiac resynchronization therapy (CRT) has led to controversies about a potential sex-specific response. In this study, we investigated to which extent this sex-specific difference in CRT outcome could be explained by differences in baselin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal cardiovascular imaging 2019-05, Vol.20 (5), p.504-511
Hauptverfasser: Beela, Ahmed S, Duchenne, Jürgen, Petrescu, Aniela, Ünlü, Serkan, Penicka, Martin, Aakhus, Svend, Winter, Stefan, Aarones, Marit, Stefanidis, Evangelos, Fehske, Wolfgang, Willems, Rik, Szulik, Mariola, Kukulski, Tomasz, Faber, Lothar, Ciarka, Agnieszka, Neskovic, Aleksandar N, Stankovic, Ivan, Voigt, Jens-Uwe
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Aims Observation of better outcome in women after cardiac resynchronization therapy (CRT) has led to controversies about a potential sex-specific response. In this study, we investigated to which extent this sex-specific difference in CRT outcome could be explained by differences in baseline characteristics between both sexes. Methods and results We retrospectively analysed data from a multicentre registry of 1058 patients who received CRT. Patients were examined by echocardiography before and 12 ± 6 months after implantation. Response was defined as ≥15% reduction of left ventricular end-systolic volume at follow-up. Patient’s characteristics at baseline, including New York Heart Association class, ejection fraction, QRS width and morphology, ischaemic aetiology of cardiomyopathy (ICM), number of scarred segments, age at implantation, atrial fibrillation, and mechanical dyssynchrony (Dyss) were analysed. Patients were followed for a median duration of 59 months. Primary end point was all-cause mortality. Women (24% of the population) had less ICM (23% vs. 49%, P 
ISSN:2047-2404
2047-2412
DOI:10.1093/ehjci/jey231